Therapeutic targets in the ARF tumor suppressor pathway.
about
Transcription-independent ARF regulation in oncogenic stress-mediated p53 responsesTumor suppressor ARF promotes non-classic proteasome-independent polyubiquitination of COMMD1RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesisMultiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signalingNucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stressesThe ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice.ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon.Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint.A conserved domain in exon 2 coding for the human and murine ARF tumor suppressor protein is required for autophagy induction.Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part I: targeting p53, Mdm2, GADD153/CHOP, GRP78/BiP and heat shock proteins.Transcription factors that interact with p53 and Mdm2CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.Reviving the guardian of the genome: Small molecule activators of p53.Reactivating the ARF-p53 axis in AML cells by targeting ULF.ARF: a versatile DNA damage response ally at the crossroads of development and tumorigenesis.ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma.Nrk2b-mediated NAD+ production regulates cell adhesion and is required for muscle morphogenesis in vivo: Nrk2b and NAD+ in muscle morphogenesis.Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf.
P2860
Q24301836-85D5D031-0CF7-4BDF-9129-43F727001E4BQ24318304-76068DE8-4963-47A7-BFA7-6759590E27B7Q26853207-4ACCDFA7-9F39-4AE6-883C-9135CF739626Q28568378-77A3695C-57C2-4ABA-937D-7ADE09301E61Q30032662-D94FB601-90C8-4E87-8E45-EE5C8E58AB48Q33786905-F37A483F-AED0-4DDB-B242-B550A61A6600Q34148155-31C36E21-04D1-4C6D-B93D-68564BE05BABQ34518059-718FCD76-8E93-4EFA-8308-F62A472A2A7FQ35665702-17A028B4-FEE7-49E2-B386-1C51194E4C19Q36216471-38B27B3A-5024-4FB9-8DCE-08FB6CA31C8BQ37344073-589B47D5-E874-4338-BE83-FB3EC1523E59Q37410536-A719513D-80BD-40AF-8F32-527EB733331BQ38089906-192A85F3-D50D-4878-A09D-9C8524D5626CQ38541481-B35A046D-8F5F-410A-AAD8-1828254A3851Q38616175-5FF94D4B-97AE-4A62-A288-D351E4EB977DQ39205536-1260870A-4A83-4436-A168-369612638A36Q41960009-C62A80AB-252A-4EE7-89B2-098E3832D18BQ42139522-19A0109E-1F2F-4A0D-8EEA-C2E9EF92E3DDQ42143482-BAED93B2-97FE-44C3-945C-56B41ABAB2C1Q42568079-1BC90EB7-48BA-4BF0-A5A1-69AA83EBAB68Q47239822-386DE6AE-8F3B-4547-91FD-70D64CBDC8AD
P2860
Therapeutic targets in the ARF tumor suppressor pathway.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapeutic targets in the ARF tumor suppressor pathway.
@en
type
label
Therapeutic targets in the ARF tumor suppressor pathway.
@en
prefLabel
Therapeutic targets in the ARF tumor suppressor pathway.
@en
P2093
P2860
P1476
Therapeutic targets in the ARF tumor suppressor pathway
@en
P2093
Anthony J Apicelli
Anthony J Saporita
Jason D Weber
P2860
P304
P356
10.2174/092986707781058869
P577
2007-01-01T00:00:00Z